RACHEL SCHIFF to Receptor, IGF Type 1
This is a "connection" page, showing publications RACHEL SCHIFF has written about Receptor, IGF Type 1.
Connection Strength
0.089
-
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res. 2008 Feb 01; 68(3):826-33.
Score: 0.073
-
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Res Treat. 2006 Aug; 98(3):315-27.
Score: 0.016